randomised trial

Lithera Announced The Treatment of First Patient with LIPO-202 in IIb RESET Trial
Mar 15, 2013
Lithera has announced the treatment of first patient with LIPO-202 (Salmeterol Xinafoate for Injection) in the Phase IIb RESET trial. LIPO-202 is an injectable pharmaceutical designed to produce aesthetic reduction of subcutaneous ...

Tags: pharmaceutical, drug, medical
Phytopharm Has Announced Results of Its Phase II for Patients with Parkinson's Disease
Feb 20, 2013
Phytopharm has announced results of its Phase II, randomised trial of Cogane in unmedicated patients with Parkinson's disease. More than four hundred subjects with early-stage Parkinson's disease were randomly chosen to receive either ...

Tags: PhytopharmPhase II, randomised trial, Parkinson's disease
Janssen Submits Bedaquiline (TMC207) New Drug Application (Nda) to FDA for Approval.
Dec 4, 2012
Janssen Research & Development company has submitted bedaquiline (TMC207) new drug application (NDA) to the US Food and Drug Administration (FDA) for approval. Bedaquiline,an investigational drug administered orally,is used as part of ...

Tags: FDA, new drug application, investigational drug, pulmonary